Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2
Sha Chen, Qian Wang, Andriana Christodoulou, Nikolaos Mylonas, Diane Bakker, Rianne Nederlof, Markus W. Hollmann, Nina C. Weber, Ruben Coronel, Vincent Wakker, Vincent M. Christoffels, Ioanna Andreadou, Coert J. Zuurbier
Topics & Concepts
EmpagliflozinMedicineCanagliflozinLibrary scienceDiabetes mellitusType 2 diabetesEndocrinologyComputer scienceDiabetes Treatment and ManagementNeuroendocrine Tumor Research AdvancesHyperglycemia and glycemic control in critically ill and hospitalized patients